Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 2, 1999, Pages 761-767

  Zhang, Xun ^a   Horwitz, Gregory A ^a   Heaney, Anthony P ^a   Nakashima, Masahiro ^a   Prezant, Toni R ^a   Bronstein, Marcello D ^b   Melmed, Shlomo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL TRANSFORMATION; CHROMOSOME LOSS; GENE EXPRESSION REGULATION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IN SITU HYBRIDIZATION; MOLECULAR CLONING; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0033018670     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.2.5432     Document Type: Article

References (36)

1. 1. Kontogeorgos G, Kovacs K, Horvath E, Scheithauer BW. 1991 Multiple adenomas of the human pituitary. A retrospective autopsy study with clinical implications. J Neurosurg. 74:243-247.
2. 2. Molitch ME, Russell EJ. 1990 The pituitary "incidentaloma". Ann Intern Med. 112:925-931.
3. 3. Melmed S, Braunstein GD, Chang RJ, Becker DP. 1986 Pituitary tumors secreting growth hormone and prolactin. Ann Intern Med. 105:238-253.
4. 4. Wilson CB. 1990 Role of surgery in the management of pituitary tumors. Neurosurg Clin North Am. 1:139-159.
5. 5. Shimon I, Melmed S. 1997 Pituitary tumor pathogenesis. J Clin Endocrinol Metab. 82:1675-1681.
6. 6. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
7. 8 and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:566-568.
8. 8. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL. 1991 ras mutations in human pituitary tumors. J Clin Endocrinol Metab. 74:914-919.
9. 9. Pei L, Melmed S, Scheithauer B, Kovacs K, Prager D. 1994 H-ras mutations in human pituitary carcinoma metastasis. J Clin Endocrinol Metab. 78:842-846.
10. 10. Bale AE, Norton JA, Wong EL, et al. 1991 Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. Cancer Res. 51:1154-1157.
11. 11. Bates AS, Farrell WE, Bicknell EJ, et al. 1997 Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab. 82:818-824.
12. 12. Takino H, Herman V, Weiss M, Melmed S. 1995 Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness. J Clin Endocrinol Metab. 80:1733-1738.
13. 13. Jacks T, Fazeli A, Wschmitt EM, Bronson RT, Goodell MA, Weinberg RA. 1992 Effects of an RB mutation in the mouse. Nature. 359:295-300.
14. 14. Nakayama K, Ishida N, Shirane N, et al. 1996 Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:707-720.
15. 15. Fero ML, Rivkin M, Tasch M, et al. 1996 A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 85:733-744.
16. 16. Pei L, Melmed S. 1997 Isolation and characterization of a pituitary tumor-specific transforming gene. Mol Endocrinol. 11:433-441.
17. 17. Zhang X, Horwitz AG, Prezant TR, et al. 1999 Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol. 13:156-166.
18. 18. Minaretzis D, Jakubowski M, Mortola JF, Pavlou SN. 1995 Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. J Clin Endocrinol Metab. 80:430-434.
19. 2+-ATPase are differentially expressed in normal and diabetic islets of Langerhans. Biochem J. 319:521-527.
20. 20 Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D. 1995 Frequent loss of heterozygosity at the retinoblasoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res. 55:1613-1616.
21. 21. Chandrasekharappa SC, Guru SC, Manickam P, et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 276:404-407.
22. 22. Boggild MD, Jenkinson S, Pistorello M, et al. 1994 Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab. 78:387-392.
23. 23. Herman V, Drazin NZ, Gonsky R, Melmed S. 1993 Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab. 77:50-55.
24. 24. Prezant TR, Levine J, Melmed S. 1998 Molecular characterization of the Menl tumor supressor gene in sporadic pituitary tumors. J Clin Endocrinol Metab. 83:1388-1391.
25. 25. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. 1989 GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyvlase in human pituitary tumors. Nature. 340:692-696.
26. 26. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
27. 27. Folkman J, Klagsbrun M. 1987 Angiogenic factors. Science. 235:442-447.
28. 28. Hanahan D, Folkman J. 1996 Pattern and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:353-346.
29. 29. Relf M, LeJeune S, Scott PAE, et al. 1997 Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57:963-969.
30. 30. Yamanaka Y, Friess H, Buchler M, et al. 1993. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res. 53:5289-5296.
31. 31. Gold LI, Saxena B, Mittal KR, et al. 1994 Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res. 54:2347-2358.
32. 32. Zimmering MB, Katsumata N, Sato Y, et al. 1993 Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. J Clin Endocrinol Metab. 76:1182-1187.
33. 33. Ray D, Melmed S. 1997 Pituitary cytokine and growth factor expression and action. Endocr Rev. 18:206-228.
34. 34. Shimon I, Huttner A, Said J, Spirina OM, Melmed S. 1996 Heparin-binding secretory transforming gene (hst) facilitates rat lacotrope cell tumorigenesis and induces prolactin gene transcription. J Clin Invest. 97:187-195.
35. 35. Gonsky R, Herman V, Melmed S, Fagin J. 1991 Transforming DNA sequences present in human prolactin secreting pituitary tumors. Mol Endocrinol. 5:1687-1695.
36. 36 Shimon I, Hinton DR, Weiss MH, Melmed S. 1998 Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness. Clin Endocrinol (Oxf). 48:23-29.